Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-20

Clinical Trial Update: Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients

View source ↗

Summary

Terminated clinical trial evaluating whether adrenomedullin can detect pancreatic cancer in patients with new-onset diabetes. The study was sponsored by the Uni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Diabetes Mellitus, Adult-Onset, Diabetes Complications | Status: TERMINATED